Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer bij ACOTEC SCIENTIFIC HOLDINGS LIMITED
Actieve functies van Ulrich Reinhold Speck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 29-01-2021 | - |
Loopbaan van Ulrich Reinhold Speck
Eerdere bekende functies van Ulrich Reinhold Speck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 01-01-2001 | 18-01-2017 |
General Counsel | 14-01-2002 | 18-01-2017 | |
Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 01-01-2000 | 01-01-2001 |
Opleiding van Ulrich Reinhold Speck
Freie Universität Berlin | Doctorate Degree |
Statistieken
Internationaal
Duitsland | 4 |
Kaaimaneilanden | 2 |
Operationeel
Founder | 1 |
General Counsel | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Consumer Services | 3 |
Health Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |